Critical Care

official impact factor 4.60
Search for
Advanced search
Critical Care
Tools
Share this article

This article is part of the supplement: Severe sepsis and drotrecogin alfa (activated)

Highly Access

Clinical trials in severe sepsis with drotrecogin alfa (activated)

Pierre-François Laterre

Critical Care 2007, 11(Suppl 5):S5 doi:10.1186/cc6156

Accesses  

  • Last 30 days: 72 accesses
  • Last 365 days: 833 accesses
  • All time: 6087 accesses

Cited by

BioMed Central: 2 citations

Review   Free Highly Accessed

Recombinant human activated protein C: current insights into its mechanism of action

Marcel Levi, Tom van der Poll Critical Care 2007, 11(Suppl 5):S3 (19 December 2007)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Introduction   Free Highly Accessed

Introduction: severe sepsis and drotrecogin alfa (activated)

Antonio Artigas, Claude D Martin Critical Care 2007, 11(Suppl 5):S1 (19 December 2007)

Full text | PDF | PubMed

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations